Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada · Delayed Price · Currency is CAD | Market Cap | 1.22M -31.1% |
| Revenue (ttm) | n/a |
| Net Income | -305.88K |
| EPS | -0.01 |
| Shares Out | 61.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,000 |
| Open | 0.0200 |
| Previous Close | 0.0200 |
| Day's Range | 0.0200 - 0.0200 |
| 52-Week Range | 0.0150 - 0.0350 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 21, 2026 |
About Genix Pharmaceuticals
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal healt... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Genix Pharmaceuticals Announces Change To CFO
Vancouver, British Columbia, May 5, 2026 - TheNewswire – Genix Pharmaceuticals Corporation (TSX-V: GENX) (“Genix” or the “Company”) announces the resignation of Mr. Danny Lee as Chief Financial Office...
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") wishes to clarify an error in its news release dated Septemb...
Genix Pharmaceuticals Closes Private Placement
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") announces that it has closed its previously announced non-...
Genix Announces TSX-V Approval of Warrant Amendments
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that pursuant to its news release ...
Genix Announces Warrant Repricing and Seeks Extension
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an appli...
Genix Announces AGM Results
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") is pleased to report the results of the Annual G...
Genix Receives Approval to Extend Warrants from the TSX Venture Exchange
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2022) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has received approva...
Genix Proposes to Extend Warrants
Vancouver, British Columbia--(Newsfile Corp. - July 20, 2022) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an applicat...